Search - tctmd.com

Displaying 361 - 380 of 421

Sort: Relevancy | Date

Presentation TCT 2012

Approach to the Patient with Renal Failure and Multivessel CAD

Presenter: Harry Phillips

October 24, 2012

Presentation TCT 2012

TCT-9. Morphological Assessment of Renal Arteries After Radiofrequency Catheter-based Sympathetic Denervation in a Porcine Model

Presenter: Michael Joner

October 23, 2012

Presentation TCT 2012

TCT-356: Circumferential Therapeutic Ultrasound for the Treatment of Resistant Hypertension: Preliminary Results of Human Feasibility Study (SOUND-ITV)

Presenter: Peter Neuzil

October 23, 2012

Presentation TCT 2012

TCT-16. Renal Artery Nerve Distribution and Density in the Porcine Model: Biological Implications for the Development of Radiofrequency Ablation Therapies

Presenter: Armando Tellez

October 23, 2012

Presentation TCT 2012

TCT-15. Histo-morphometric Evaluation of 2D Characteristics and 3D Sympathetic Renal Nerve Distribution in Hypertensive vs. Normotensive Patients

Presenter: Giuseppe Sangiorgi

October 23, 2012

Presentation TCT 2012

TCT-14. Effects of Renal Sympathetic Denervation on Heart Rate and Atrioventricular Conduction in Patients with Resistant Hypertension

Presenter: Christian Ukena

October 23, 2012

Presentation TCT 2012

TCT-13. Renal Resistive Indices, Urinary Albumin Excretion and Renal Function in Patients with Resistant Hypertension After Catheter-based Renal Sympathetic Denervation

Presenter: Felix Mahfoud

October 23, 2012

Presentation TCT 2012

TCT-12. Long-term Follow-up of Catheter-based Renal Denervation for Resistant Hypertension Confirms Durable Blood Pressure Reduction

Presenter: Markus Schlaich

October 23, 2012

Presentation TCT 2012

TCT-11. Renal Sympathetic Denervation - Inducing an Instantaneous and Persisting 24h Ambulatory Blood Pressure Drop in Patients With Resistant Hypertension – Results from the...

Presenter: Alexander Plehn

October 23, 2012

Presentation TCT 2012

TCT-10. Efficacy of Renal Denervation is Positively Impacted by Longitudinal Treatments

Presenter: Meital Mazor

October 23, 2012

Presentation TCT 2012

State-of-the-Field Keynote: The Next Challenge: Improving Technical Efficiency and Biological Response (Nonresponders)

Presenter: Deepak Bhatt

October 23, 2012

Presentation TCT 2012

Preclinical Review: Perirenal Nerve Distribution, Density, and Quantification: Implications for the Evaluation of Device Safety and Efficacy

Presenter: Renu Virmani

October 23, 2012

Presentation TCT 2012

Hypertension: Renal Denervation

Presenter: Deepak Bhatt

October 23, 2012

Presentation TCT 2012

Essentials of Renal Artery Disease: Guidelines, Assessment, and Outcomes

Presenter: Jeffrey Olin

October 23, 2012

Presentation TCT 2012

Early Human Clinical Studies: Patient Selection, Technical Considerations, and Endpoints(5)

Presenter: Paul Sobotka

October 23, 2012

Presentation TCT 2012

Treating Fibromuscular Dysplasia in the Renal Artery

Presenter: Robert Lookstein

October 22, 2012

Presentation TCT 2012

Selecting the Patient Most Likely to Benefit from Renal Intervention

Presenter: Massoud Leesar

October 22, 2012

Presentation TCT 2012

Role of Renal Revascularization in 2012 and Predictions for the Future

Presenter: Michael Jaff

October 22, 2012

Presentation TCT 2012

Renal Sympathetic Denervation for HTN

Presenter: Lynne Hinterbuchner

October 22, 2012

Presentation TCT 2012

Management of Mesenteric Arteries in EVAR

Presenter: Jacques Busquet

October 22, 2012

Advertisement

Approach to the Patient with Renal Failure and Multivessel CAD

TCT-9. Morphological Assessment of Renal Arteries After Radiofrequency Catheter-based Sympathetic Denervation in a Porcine Model

TCT-356: Circumferential Therapeutic Ultrasound for the Treatment of Resistant Hypertension: Preliminary Results of Human Feasibility Study (SOUND-ITV)

TCT-16. Renal Artery Nerve Distribution and Density in the Porcine Model: Biological Implications for the Development of Radiofrequency Ablation Therapies

TCT-15. Histo-morphometric Evaluation of 2D Characteristics and 3D Sympathetic Renal Nerve Distribution in Hypertensive vs. Normotensive Patients

TCT-14. Effects of Renal Sympathetic Denervation on Heart Rate and Atrioventricular Conduction in Patients with Resistant Hypertension

TCT-13. Renal Resistive Indices, Urinary Albumin Excretion and Renal Function in Patients with Resistant Hypertension After Catheter-based Renal Sympathetic Denervation

TCT-12. Long-term Follow-up of Catheter-based Renal Denervation for Resistant Hypertension Confirms Durable Blood Pressure Reduction

TCT-11. Renal Sympathetic Denervation - Inducing an Instantaneous and Persisting 24h Ambulatory Blood Pressure Drop in Patients With Resistant Hypertension – Results from the...

TCT-10. Efficacy of Renal Denervation is Positively Impacted by Longitudinal Treatments

State-of-the-Field Keynote: The Next Challenge: Improving Technical Efficiency and Biological Response (Nonresponders)

Preclinical Review: Perirenal Nerve Distribution, Density, and Quantification: Implications for the Evaluation of Device Safety and Efficacy

Hypertension: Renal Denervation

Essentials of Renal Artery Disease: Guidelines, Assessment, and Outcomes

Early Human Clinical Studies: Patient Selection, Technical Considerations, and Endpoints(5)

Treating Fibromuscular Dysplasia in the Renal Artery

Selecting the Patient Most Likely to Benefit from Renal Intervention

Role of Renal Revascularization in 2012 and Predictions for the Future

Renal Sympathetic Denervation for HTN

Management of Mesenteric Arteries in EVAR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content